选择性5-羟色胺再摄取抑制剂所致性功能障碍:当前的治疗观点
Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives.
作者信息
Atmaca Murad
机构信息
Department of Psychiatry, Firat University School of Medicine, Elazig, Turkey.
出版信息
Neuropsychiatr Dis Treat. 2020 Apr 20;16:1043-1050. doi: 10.2147/NDT.S185757. eCollection 2020.
Any type of sexual dysfunction is an important problem in half of the patients with depressive disorder. On the other hand, one to a quarter of people without any depressive disorder experience sexual dysfunction. Antidepressant agents can lead to all types of sexual side effects including arousal, libido, orgasm and ejaculation problems. Selective serotonin reuptake inhibitors (SSRIs) are a widely used class of drugs which are prescribed for the treatment of a variety of disorders, including major depressive disorder, obsessive-compulsive disorder, posttraumatic stress disorder, panic disorder, generalized anxiety disorder, and impulse control disorders. It has been reported that one in eight people have utilized one of the SSRIs in the past 10 years. Some studies reported up to 80% of SSRI-induced sexual side effects. Management of SSRI-induced sexual dysfunction seems to be complex and hard. In this paper, SSRI-induced sexual dysfunction and new perspectives in the management of this problem were reviewed.
在半数抑郁症患者中,任何类型的性功能障碍都是一个重要问题。另一方面,在没有任何抑郁症的人群中,有四分之一到二分之一的人会经历性功能障碍。抗抑郁药可导致各种类型的性副作用,包括性唤起、性欲、性高潮和射精问题。选择性5-羟色胺再摄取抑制剂(SSRI)是一类广泛使用的药物,用于治疗多种疾病,包括重度抑郁症、强迫症、创伤后应激障碍、恐慌症、广泛性焦虑症和冲动控制障碍。据报道,在过去10年中,八分之一的人使用过其中一种SSRI。一些研究报告称,高达80%的性功能副作用是由SSRI引起的。SSRI引起的性功能障碍的管理似乎复杂且困难。本文综述了SSRI引起的性功能障碍以及该问题管理的新观点。